progesterone + Progesterone
ApprovedUNKNOWN 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
IVF - Luteal Phase Support After Embryo Transfer
Conditions
IVF - Luteal Phase Support After Embryo Transfer
Trial Timeline
Apr 1, 2006 → Dec 1, 2008
NCT ID
NCT00708539About progesterone + Progesterone
progesterone + Progesterone is a approved stage product being developed by Merck for IVF - Luteal Phase Support After Embryo Transfer. The current trial status is unknown. This product is registered under clinical trial identifier NCT00708539. Target conditions include IVF - Luteal Phase Support After Embryo Transfer.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00708539 | Approved | UNKNOWN |
Competing Products
1 competing product in IVF - Luteal Phase Support After Embryo Transfer
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| COL-1620 + Gonadotropin-releasing hormone (GnRH) analogue + Follicle-stimulating hormone (FSH) + Human Chorionic Gonadotropin (hCG) | Merck | Phase 3 | 77 |